PolyPid to Present at the Investor Summit Virtual Conference on August 18, 2021

PETACH TIKVA, Israel, Aug. 09, 2021 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today announced that Executive Vice President and Chief Financial Officer